Ocular streptococcal infections: A clinical and microbiological review

被引:9
|
作者
Nanayakkara, Upeka [1 ]
Khan, Muhammad A. [1 ]
Hargun, Dilnoor K. [1 ]
Sivagnanam, Shobini [2 ,3 ]
Samarawickrama, Chameen [4 ,5 ,6 ]
机构
[1] Univ New South Wales, Sydney, NSW, Australia
[2] Blacktown Hosp, Sydney, NSW, Australia
[3] Australian Clin Labs, Sydney, NSW, Australia
[4] Univ Sydney, Sydney, NSW, Australia
[5] Westmead Inst Med Res, Translat Ocular Res & Immunol Consortium TORIC, Westmead, NSW, Australia
[6] Westmead Inst Med Res WIMR, Room 3 09,176 Hawkesbury Rd, Westmead, NSW 2145, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
Streptococcus; Prevalence; Antibiotic resistance; Endophthalmitis; Conjunctivitis; Keratitis; Ocular infection; PURULENT BACTERIAL CONJUNCTIVITIS; IN-VITRO SUSCEPTIBILITY; 1.5-PERCENT EYE DROPS; MICROBIAL KERATITIS; ANTIBIOTIC SUSCEPTIBILITY; RISK-FACTORS; INTRAVITREAL INJECTION; RESISTANCE PATTERNS; ETIOLOGIC DIAGNOSIS; OPHTHALMIC SOLUTION;
D O I
10.1016/j.survophthal.2023.02.001
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Streptococcus is a diverse bacterial genus that is part of the ocular surface microbiome implicated in conjunctivitis, keratitis, endophthalmitis, dacryocystitis, and orbital cellulitis that can lead to decreased visual acuity and require surgical intervention. The pathophysiology of S. pneumoniae is well-established and the role of the polysaccharide capsule, pneumolysin, neuraminidases, and zinc metalloproteinases in ocular infections described. Additionally, key virulence factors of the viridans group streptococci such as cytolysins and proteases have been outlined, but there is a paucity of research on the remaining streptococcus species . These virulence factors tend to result in aggressive disease. Clinically, S. pneumoniae is implicated in 2.7-41.2% of bacterial conjunctivitis cases, more predominant in the pediatric population, and is implicated in 1.8-10.7% of bacterial keratitis isolates. Streptococcus bacteria are significantly implicated in acute postoperative, postintravitreal, and bleb-associated endophthalmitis, responsible for 10.3-37.5, 29.4, and 57.1% of cases, respectively. Group A and B streptococcus endogenous endophthalmitis is rare, but has a very poor prognosis. Inappropriate prescription of antibiotics in cases of nonbacterial aetiology has contributed to increasing resistance, and a clinical index is needed to more accurately monitor this. Furthermore, there is an increasing need for prospective, surveillance studies of antimicrobial resistance in ocular pathogens, as well as point-of-care testing using molecular techniques.Crown Copyright & COPY; 2023 Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:678 / 696
页数:19
相关论文
共 50 条
  • [31] Recurrence of group B streptococcal infections in infants: a systematic review
    Miselli, Francesca
    Boncompagni, Alessandra
    Costantini, Riccardo Cuoghi
    Zini, Tommaso
    Bedetti, Luca
    Buttera, Martina
    Corso, Lucia
    Creti, Roberta
    Guidotti, Isotta
    Rossi, Cecilia
    Spaggiari, Eugenio
    Lugli, Licia
    Berardi, Alberto
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2025, : 305 - 314
  • [32] Review of nanoformulations for treating ocular fungal infections
    Onugwu, Adaeze Linda
    Emencheta, Stephen Chijioke
    Sabastine, Ruth Nkechi
    Onugwu, Sabastine Obinna
    Echezona, Adaeze Chidiebere
    Nwagwu, Chinekwu Sherridan
    Chime, Salome Amarachi
    Ezike, Tobechukwu Christian
    Eze, Oluebubechukwu P.
    Onyeyilim, Ebuka Leonard
    Attama, Anthony Amaechi
    Prajapati, Bhupendra Gopalbhai
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 101
  • [33] A Systematic Review of Multi-decade Antibiotic Resistance Data for Ocular Bacterial Pathogens in the United States
    Bispo, Paulo J. M.
    Sahm, Daniel F.
    Asbell, Penny A.
    OPHTHALMOLOGY AND THERAPY, 2022, 11 (02) : 503 - 520
  • [34] Common Microbes and Antibiotic Resistance in Ocular Infections at an Urban Public Tertiary Care Hospital
    Geevarghese, Alexi
    Shah, Payal
    Lopez, Jennifer
    Tsui, Edmund
    Raju, Leela
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2022, 30 (02) : 481 - 486
  • [35] Ocular Surface Infections in Northeastern State of Malaysia: A 10-Year Review of Bacterial Isolates and Antimicrobial Susceptibility
    Rahman, Zaidah A.
    Harun, Azian
    Hasan, Habsah
    Mohamed, Zeehaida
    Noor, Siti S. Md.
    Deris, Zakuan Z.
    Ismail, Nabilah
    Hassan, Asma S.
    Ahmad, Fadzhilah
    Yaakub, Azhany
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2013, 39 (05): : 355 - 360
  • [36] Bacteriological study of the strains isolated from ocular infections
    Hajoui, Fatima-Zahra
    Daoudi, Naima
    Kabbaj, Hakima
    Alaoui, Ahmed
    Seffar, Myriam
    ANNALES DE BIOLOGIE CLINIQUE, 2012, 70 (06) : 689 - 694
  • [37] Clinical and Microbiological Characteristics of Mycobacterium kansasii Pulmonary Infections in China
    Guo, Yinjuan
    Cao, Yanhua
    Liu, Haican
    Yang, Jinghui
    Wang, Weiping
    Wang, Bingjie
    Li, Meilan
    Yu, Fangyou
    MICROBIOLOGY SPECTRUM, 2022, 10 (01):
  • [38] Clinical Significance and Microbiological Characteristics of Staphylococcus lugdunensis in Cutaneous Infections
    Koumaki, Dimitra
    Maraki, Sofia
    Evangelou, Georgios
    Rovithi, Evangelia
    Petrou, Danae
    Apokidou, Erato Solia
    Gregoriou, Stamatios
    Koumaki, Vasiliki
    Ioannou, Petros
    Zografaki, Kyriaki
    Doxastaki, Aikaterini
    Papadopoulou, Kalliopi
    Stafylaki, Dimitra
    Mavromanolaki, Viktoria Eirini
    Krasagakis, Konstantinos
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (15)
  • [39] Prevention of perinatal group B streptococcal infections: A review with an Indian perspective
    Narava, S.
    Rajaram, G.
    Ramadevi, A.
    Prakash, G. V.
    Mackenzie, S.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2014, 32 (01) : 6 - 12
  • [40] Ocular infections in international travelers
    Norman, Francesca F.
    Gonzalez-Lopez, Julio J.
    Gayoso-Cantero, Diego
    Vicente-Antolin, Marta
    Corbacho-Loarte, Maria-Dolores
    Lopez-Velez, Rogelio
    Gonzalez-Sanz, Marta
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2025, 63